299 related articles for article (PubMed ID: 11181687)
21. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations.
de Fraipont F; El Atifi M; Gicquel C; Bertagna X; Chambaz EM; Feige JJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4734-41. PubMed ID: 11134136
[TBL] [Abstract][Full Text] [Related]
22. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of angiogenic cytokines in the plasma of cancer patients.
Fuhrmann-Benzakein E; Ma MN; Rubbia-Brandt L; Mentha G; Ruefenacht D; Sappino AP; Pepper MS
Int J Cancer; 2000 Jan; 85(1):40-5. PubMed ID: 10585580
[TBL] [Abstract][Full Text] [Related]
24. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
[TBL] [Abstract][Full Text] [Related]
25. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
26. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis and angiogenic growth factors in Wilms tumor.
Sköldenberg EG; Christiansson J; Sandstedt B; Larsson A; Läckgren G; Christofferson R
J Urol; 2001 Jun; 165(6 Pt 2):2274-9. PubMed ID: 11371962
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of angiogenesis in non-small cell lung cancer.
Giatromanolaki A
Anticancer Res; 2001; 21(6B):4373-82. PubMed ID: 11908693
[TBL] [Abstract][Full Text] [Related]
29. Circulating angiogenesis regulators in cancer patients.
Kuroi K; Toi M
Int J Biol Markers; 2001; 16(1):5-26. PubMed ID: 11288955
[TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis, angiogenic factor expression and prognosis of bladder cancer.
Streeter EH; Crew JP
Anticancer Res; 2001; 21(6B):4355-63. PubMed ID: 11908691
[TBL] [Abstract][Full Text] [Related]
32. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
Edgren M; Lennernäs B; Larsson A; Kälkner KM
Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.
Brostjan C; Bayer A; Zommer A; Gornikiewicz A; Roka S; Benkö T; Yaghubian R; Jakesz R; Steger G; Gnant M; Friedl J; Stift A
Cancer; 2003 Nov; 98(10):2291-301. PubMed ID: 14601101
[TBL] [Abstract][Full Text] [Related]
34. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
36. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
37. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of angiogenesis in colorectal cancer.
Papamichael D
Anticancer Res; 2001; 21(6B):4349-53. PubMed ID: 11908690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
